Efficacy/Safety of a Fixed-Dose Amlodipine/Olmesartan Medoxomil-Based Treatment Regimen in Hypertensive Blacks and Non-Blacks With Uncontrolled BP on Prior Antihypertensive Monotherapy

Journal of Clinical Hypertension

Volumn 15, Issue 4, 2013, Pages 247-253

  Nesbitt, Shawna ^a   Shojaee, Ali ^b   Maa, Jen Fue ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b DAIICHI SANKYO INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE PLUS HYDROCHLOROTHIAZIDE PLUS OLMESARTAN; AMLODIPINE PLUS OLMESARTAN;

AGED; ARTICLE; BLOOD PRESSURE MONITOR; CREATININE BLOOD LEVEL; DIZZINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EDEMA; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPERTENSION; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PERIPHERAL EDEMA; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; RACE DIFFERENCE; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; URIC ACID BLOOD LEVEL;

ADULT; AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG MONITORING; DRUG SUBSTITUTION; ETHNIC GROUPS; FEMALE; HUMANS; HYPERTENSION; IMIDAZOLES; MALE; MIDDLE AGED; TETRAZOLES; TREATMENT OUTCOME;

EID: 84875838463     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12060     Document Type: Article

References (21)

1. Aronow WS, Fleg JL, Pepine CJ, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Coll Cardiol. 2011;57:2037-2114.
2. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
3. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statistics - 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:e21-e181.
4. Twagirumukiza M, De Bacquer D, Kips JG, et al. Current and projected prevalence of arterial hypertension in sub-Saharan Africa by sex, age and habitat: an estimate from population studies. J Hypertens. 2011;29:1243-1252.
5. Cooper RS, Amoah AG, Mensah GA. High blood pressure: the foundation for epidemic cardiovascular disease in African populations. Ethn Dis. 2003;13(2 Suppl 2):S48-S52.
6. Ferdinand KC, Armani AM. The management of hypertension in African Americans. Crit Pathw Cardiol. 2007;6:67-71.
7. Baruth M, Wilcox S, Egan BM, et al. Cardiovascular disease risk factor clustering among African American adults. Ethn Dis. 2011;21:129-134.
8. Weir MR, Hsueh WA, Nesbitt SD, et al. A titrate-to-goal study of switching patients uncontrolled on antihypertensive monotherapy to fixed-dose combinations of amlodipine and olmesartan medoxomil ± hydrochlorothiazide. J Clin Hypertens (Greenwich). 2011;13:404-412.
9. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111:697-716.
10. Liu X, Liu M, Tsilimingras D, Schiffrin EL. Racial disparities in cardiovascular risk factors among diagnosed hypertensive subjects. J Am Soc Hypertens. 2011;5:239-248.
11. Wright JD, Hughes JP, Ostchega Y, et al. Mean systolic and diastolic blood pressure in adults aged 18 and over in the United States, 2001-2008. Natl Health Stat Rep. 2011;35:1-22, 24.
12. Basile J, Neutel J. Overcoming clinical inertia to achieve blood pressure goals: the role of fixed-dose combination therapy. Ther Adv Cardiovasc Dis. 2010;4:119-127.
13. Nesbitt SD. Environmental, societal and genetic contributions to hypertension in African Americans. Curr Cardiovasc Risk Rep. 2008;2:181-186.
14. Flack JM, Sica DA, Bakris G, et al. Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension. 2010;56:780-800.
15. Nesbitt SD. Management of hypertension in African Americans. US Cardiol. 2009;6:59-62.
16. Nesbitt SD. Overcoming therapeutic inertia in patients with hypertension. Postgrad Med. 2010;122:118-124.
17. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105-1187.
18. Douglas JG, Bakris GL, Epstein M, et al. Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks. Arch Intern Med. 2003;163:525-541.
19. Flack JM, Sica DA. Therapeutic considerations in the African-American patient with hypertension: considerations with calcium channel blocker therapy. J Clin Hypertens (Greenwich). 2005;7(4 Suppl 1):9-14.
20. Centers for Disease Control and Prevention. Vital Signs: prevalence, treatment, and control of hypertension - United States, 1999-2002 and 2005-2008. MMWR Morb Mortal Wkly Rep. 2011;60:103-108.
21. Gosse P, Lasserre R, Minifie C, et al. Blood pressure surge on rising. J Hypertens. 2004;22:1113-1118.